The Western Ontario Rotator Cuff Index Arabic Version
Launched by CAIRO UNIVERSITY · Mar 28, 2022
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a special survey called The Western Ontario Rotator Cuff Index (WORC) that has been translated into Arabic. The goal is to see if this Arabic version can effectively measure how rotator cuff injuries affect the quality of life for Arabic-speaking patients. Researchers want to ensure that the survey accurately reflects the experiences of these patients and is reliable over time.
To participate in the study, individuals need to be between the ages of 18 and 60, be able to read and write in Arabic, and have been referred by a doctor for issues like rotator cuff tendinopathy or partial tears. However, those with other shoulder-related problems, cognitive issues, or significant health conditions that could impact the results will not be included. Participants will complete the survey and help researchers understand how well this tool works in the Arabic-speaking community.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Referred with rotator cuff tendinopathy or rotator cuff partial tear by physician.
- • Able to read and write in Arabic.
- • Their age will be Between 18 to 60 years old
- • patients with chronic inflammatory diseases will be included
- Exclusion Criteria:
- • Patients with impairments in the cervical spine, elbow, or hand affecting the shoulder function
- • Patients that have Cognitive alterations
- • Patients that have any systemic disease that may affect patient's outcome.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Yasser M. Aneis, PHD
Study Director
Cairo University
Mohsen El Sayyad, PHD
Study Chair
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials